GE HealthCare Enhances iRT Platform with Expanded AI-Driven Radiation Therapy Workflow Tools

**GE HealthCare’s Intelligent Radiation Therapy Enhancements at ASTRO 2025**

At the forefront of oncology technology, GE HealthCare unveiled significant upgrades to its Intelligent Radiation Therapy (iRT) platform during the ASTRO 2025 Annual Meeting. The enhancements are geared towards addressing long-standing delays in radiation therapy processes and streamlining complex oncology workflows that have become increasingly burdensome.

### AI-Enabled Tools for Efficient Therapy

The latest iteration of the iRT platform introduces a suite of AI-enabled tools and enhanced system integrations. These upgrades aim to provide a more efficient and faster planning and delivery process for radiation therapy. Notable among the new features is a theranostics module specifically designed to streamline the full workflow involved in radiopharmaceutical-based treatments.

### Addressing Fragmented Workflows

Over 60% of cancer patients are likely to undergo radiation therapy at some point during their treatment journey. However, the conventional workflows often experience fragmentation, causing delays that can stretch treatment schedules by weeks. According to GE HealthCare, early adopters of the iRT platform have achieved remarkable improvements, shrinking the time from simulation to treatment planning from a cumbersome seven days down to an impressive seven minutes. This transformation has been made possible through a seamless integration with RayStation, developed by RaySearch Laboratories.

### Advanced Features for Optimized Workflow

The updates to the iRT platform include several innovative features that enhance operational efficiency:

– **Analytics Dashboards:** Tailored for administrators, these dashboards offer insights into workflow performance.
– **Staff Scheduling Tools:** Facilitating better allocation and management of personnel resources.
– **AI-Based Auto-Segmentation:** Utilizing GE’s MR Contour DL, this feature assists in the precise identification of organs-at-risk, alongside the capability to incorporate third-party solutions.
– **Virtual Reality Support:** A new integration with a VR training and patient education app enhances both clinician training and patient engagement.

The vendor-neutral design of the platform ensures compatibility with widely used Electronic Medical Records (EMRs), oncology information systems, and various interoperability frameworks, paving the way for cohesive user experiences.

### Transformative Impact on Patient and Clinician Experience

Ben Newton, general manager for oncology solutions at GE HealthCare, expressed the company’s vision by stating, “We are transforming the radiation therapy experience for patients and clinicians with our Intelligent Radiation Therapy solution, helping clinicians move from diagnosis to treatment in minutes, not days.” This commitment underscores the importance of innovation in reducing wait times and enhancing patient care.

### Innovations in Radioligand Therapy Workflow

The newly added iRT functionalities specifically for theranostics aim to refine patient assessment, scheduling, dosing, and clinical review workflows. By addressing the procedural and communication challenges faced in radioligand therapies, the platform positions itself as an essential tool in the oncology landscape.

Dr. Ranjini Tolakanahalli, director of photon physics at Miami Cancer Institute, praised the collaboration with GE HealthCare, highlighting how iRT is tailored to meet the fast-paced changes in the field of radiopharmaceuticals.

### Updates on MIM Maestro and MR Direct Solutions

In addition to the iRT platform enhancements, GE HealthCare is also showcasing updates to other solutions like MIM Maestro and iRT MR Direct. These tools support MR-only planning specifically for brain, head and neck, and pelvic cancers, thereby further advancing the precision and personalization of radiation therapy.